Siga Technologies (SIGA) Research & Development (2010 - 2025)
Siga Technologies (SIGA) posted Research & Development of $7.1 million for Q3 2025, up 60.39% on a QoQ basis from $4.4 million in Q2 2025, and up 133.22% year-over-year from $3.0 million in Q3 2024.
Siga Technologies (SIGA) Research & Development (2010 - 2025) Analysis & Trends
Siga Technologies' Research & Development history runs 16 years deep, the most recent figure standing at $7.1 million for Q3 2025.
- Quarterly Research & Development rose 133.22% year-over-year to $7.1 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $18.3 million (up 57.61% YoY) and the FY2024 annual result came in at $12.3 million, down 25.06% from the prior year.
- Research & Development was $7.1 million for Q3 2025 at Siga Technologies, up from $4.4 million in the prior quarter.
- Across five years, Research & Development topped out at $7.1 million in Q3 2025 and bottomed at $2.1 million in Q4 2021.
- A 5-year average of $4.0 million and a median of $3.5 million in 2025 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development soared 202.13% — and 2023, when it tumbled 59.14%.
- Siga Technologies' Research & Development stood at $2.1 million in 2021, then soared by 199.29% to $6.4 million in 2022, then tumbled by 59.14% to $2.6 million in 2023, then gained by 27.74% to $3.3 million in 2024, then surged by 110.95% to $7.1 million in 2025.
- Business Quant data shows SIGA's Research & Development at $7.1 million in Q3 2025, $4.4 million in Q2 2025, and $3.5 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 696.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 180.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.37 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 138.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 248.60 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 296.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 97.00 Mn |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 7.05 Mn |
| Jun 30, 2025 | 4.40 Mn |
| Mar 31, 2025 | 3.46 Mn |
| Dec 31, 2024 | 3.34 Mn |
| Sep 30, 2024 | 3.02 Mn |
| Jun 30, 2024 | 2.89 Mn |
| Mar 31, 2024 | 3.05 Mn |
| Dec 31, 2023 | 2.62 Mn |
| Sep 30, 2023 | 3.65 Mn |
| Jun 30, 2023 | 5.12 Mn |
| Mar 31, 2023 | 5.05 Mn |
| Dec 31, 2022 | 6.41 Mn |
| Sep 30, 2022 | 5.73 Mn |
| Jun 30, 2022 | 6.84 Mn |
| Mar 31, 2022 | 3.55 Mn |
| Dec 31, 2021 | 2.14 Mn |
| Sep 30, 2021 | 3.24 Mn |
| Jun 30, 2021 | 2.26 Mn |
| Mar 31, 2021 | 2.30 Mn |
| Dec 31, 2020 | 3.01 Mn |